David S. Glatt Partner
Contact Information
16 Abba Hillel Silver Rd.Ramat Gan 5250608, Israel
Tel: 972 3 610 3890 Fax: 972 3 610 3111
Email: dglatt@meitar.com
“intelligent, attentive and a pleasure to deal with;
great problem solver”
Chambers and Partners
Biography
“known for his excellent capabilities in cross-border M&A transactions as well as capital markets work”
Chambers and Partners
David S. Glatt is a partner in the corporate and securities group. David represents issuers and underwriters in public and private debt and equity offerings, investors and companies in venture capital and private equity transactions, and acquirers and targets in M&A deals. He also provides general securities compliance and corporate advice for many NASDAQ-listed foreign private issuers, as well as ongoing corporate counsel for privately held and venture-backed companies. In addition, he advises leading banks and financial institutions in Israel and abroad on derivative transactions, and is the co-author of the official ISDA country netting opinion for Israel. Chambers Global lists him as a leading individual for Israel in Corporate/M&A and Capital Markets. Prior to moving to Israel and joining Meitar in the fall of 1998, he practiced in the corporate finance and mergers and acquisitions departments of the New York office of Skadden, Arps, Slate, Meagher & Flom LLP for five years.
David received his J.D. degree in 1993 from Columbia University School of Law, where he was a Harlan Fiske Stone Scholar, and his B.A. degree cum laude from Yeshiva University in 1989.
Representative Experience
- Representation of TMX Group Limited in its acquisition of iNDEX Research and Development Indices Ltd.
- Representation of Outbrain Inc. in its $1.0 billion acquisition of Tead S.A. and related acquisition financing.
- Representation of BioCatch Ltd. in the sale of a majority position to Permira Growth Opportunities reflecting a $1.3 billion valuation.
- Representation of Ermetic Ltd. in its $265 million sale to Tenable Holdings, Inc.
- Representation of Elmo Motion Control Ltd. in its $700 million sale to Bosch Rexroth.
- Representation of Similarweb Ltd. in multiple acquisitions (Embee Mobile, Rank Ranger, 42Matters and Admetricks).
- Representation of Abry Partners and its portfolio company I.D. Systems, Inc. in the $140 leveraged acquisition of Pointer Telocation Ltd.
- Representation of Clarizen Ltd. in its $110 million MBO by K1 Investment Management.
- Representation of Sarine Technologies Ltd. in its acquisition of a majority stake in The Gem Certification & Assurance Lab, Inc.
- Representation of Objet Ltd. in its proposed Nasdaq IPO and in its $3.0 billion merger of equals with Stratasys, Inc.
- Representation of Neuroderm Ltd. in its $1.1 billion sale to Mitsubishi Tanabe.
- Representation of Enzymotec Ltd. in its $210 million sale to Frutarom Industries Ltd.
- Representation of Databricks, Inc. in its acquisition of Redash.IO Ltd.
- Representation of Elastic N.V. in its acquisition of Build Security Ltd.
- Representation of Synopsys, Inc. in its acquisitions of Terrain Technologies Ltd. and Concertio, Inc.
- Representation of Similarweb in its NYSE IPO and secondary offering.
- Representation of Cellebrite DI Ltd. in its business combination with TWC Tech Holdings II Corp. and related Nasdaq listing.
- Representation of Neuroderm Ltd. in its Nasdaq IPO.
- Representation of Enzymotec Ltd. in its Nasdaq IPO and follow on offering.
- Representation of Lumenis Ltd. in its Nasdaq IPO.
- Representation of MediWound Ltd. in its Nasdaq IPO and follow on offerings.
- Representation of Chemomab Therapeutics Ltd. in various public offerings.
- Representation of InspireMD, Inc. in various public offerings.
- Representation of the managers in the $500 million principal amount 6.7% Notes 144A/Reg S offering by The Israel Electric Corporation.
- Representation of eBay in its $169 million acquisition of Fraud Sciences.
- Representation of Actimize in its proposed IPO.
- Representation of M-Systems in its $1.5 billion sale to SanDisk Corporation.
- Representation of Kashya in its $153 million sale to EMC Corporation.
- Representation of Omrix Biopharmaceuticals in its IPO and follow-on offering.
- Representation of Cyota in its $145 million sale to RSA Security.
- Representation of Shopping.com in its IPO and in its $634 million sale to eBay.
- Representation of the underwriters in offerings by Mellanox Technologies, NICE Systems, Saifun Semiconductors and Audiocodes.
- Representation of the International Swaps and Derivatives Association (ISDA) on issues related to netting under Israeli law, and the adoption of netting legislation in Israel.
- Representation of numerous North American, European and Japanese commercial and investment banks and other financial institutions on Israeli law issues arising in the context of a broad range of derivatives transactions and products.
- Representation of leading U.S. and Israeli venture capital funds in numerous investments.